MAVS Gene

MAVS Gene

Introduction

Pathway Diagram

```mermaid
flowchart TD
MAVS["MAVS<br/>Mitochondrial Antiviral<br/>Signaling Protein"]
MITOCHONDRIA["Mitochondria<br/>Localization"]
AUTOPHAGY["Autophagy<br/>Pathway"]
INNATE_IMMUNITY["Innate Immunity<br/>Response"]
IMMUNE_RESPONSE["Immune Response<br/>Activation"]
FIP200["FIP200<br/>Autophagy Regulator"]
AMBRA1["AMBRA1<br/>Autophagy Protein"]
RIPK1["RIPK1<br/>Cell Death Regulator"]
HMGB1["HMGB1<br/>Damage Signal"]
ALS["ALS<br/>Amyotrophic Lateral<br/>Sclerosis"]
MS["Multiple Sclerosis<br/>Neuroinflammation"]
MAPK["MAPK<br/>Signaling"]
PI3K_AKT["PI3K/AKT<br/>Survival Pathway"]
MTOR["mTOR<br/>Growth Signaling"]
OXPHOS["Oxidative<br/>Phosphorylation"]
NEURODEGENERATION["Neurodegeneration<br/>Outcomes"]

MAVS Gene

Introduction

Pathway Diagram

The MAVS gene (Mitochondrial Antiviral Signaling Protein) encodes a critical adaptor protein that serves as the central hub for Rig-I-like receptor (RLR) signaling in the innate immune response. Also known as VISA (Virus-Induced Signaling Adaptor), IPS-1 (IFN-beta Promoter Stimulator Protein 1), and CARDIF (CARD Adaptor Inducing IFN-beta), MAVS bridges viral RNA detection by cytosolic sensors to the activation of downstream signaling cascades that induce type I interferons and inflammatory cytokines [1].

Located on chromosome 20p13, MAVS is expressed ubiquitously with highest levels in liver, heart, and brain. In the central nervous system, MAVS is expressed in [neurons](/cell-types/neurons), [astrocytes](/cell-types/astrocytes), and [microglia](/cell-types/microglia-neuroinflammation), where it plays crucial roles in antiviral defense and neuroinflammation. Recent research has revealed that MAVS dysregulation contributes to the pathogenesis of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurodegenerative conditions through mechanisms involving chronic innate immune activation, mitochondrial dysfunction, and neuroinflammation [4][5][9].[@mavs_neuro]

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background-color: #1e88e5; color: white;">MAVS (Mitochondrial Antiviral Signaling Protein)</th></tr>
<tr><td><strong>Official Symbol</strong></td><td>MAVS</td></tr>
<tr><td><strong>Full Name</strong></td><td>Mitochondrial Antiviral Signaling Protein</td></tr>
<tr><td><strong>Other Names</strong></td><td>VISA, IPS-1, CARDIF</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>20p13</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>57468</td></tr>
<tr><td><strong>OMIM</strong></td><td>609588</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000088888</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>Q9Y2H9</td></tr>
<tr><td><strong>Expression</strong></td><td>Ubiquitous (liver, heart, brain)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/autoimmune" style="color:#ef9a9a">Autoimmune</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">403 edges</a></td>
</tr>
</table>
</div>

Gene Structure and Protein Architecture

Genomic Organization

The MAVS gene spans approximately 35 kb on chromosome 20 and consists of 10 coding exons. The gene produces multiple transcript variants through alternative splicing, with the major isoform encoding a protein of 540 amino acids. The promoter region contains NF-κB and IRF response elements, enabling inducible expression [1].

Protein Domain Structure

MAVS protein contains several functional domains that enable its signaling functions:

The transmembrane domain is essential for MAVS function, as it localizes the protein to mitochondria where it can interact with viral sensors and downstream signaling molecules. Mutations in this domain can disrupt signaling and increase susceptibility to viral infections [1][3].

Normal Biological Functions

RIG-I-Like Receptor Signaling

MAVS serves as the central adaptor for RLR signaling:

Upstream Activation:

• Cytosolic RIG-I and MDA5 detect viral RNA through their C-terminal RD domains
• Upon viral RNA binding, RIG-I undergoes conformational change exposing its CARD domain
• RIG-I CARD interacts with MAVS CARD through homotypic CARD-CARD interactions [1][2]

• MAVS activates TBK1 and IKKε kinases
• TBK1 phosphorylates IRF3 and IRF7 transcription factors
• IKK complex activates NF-κB signaling
• IRF3/7 and NF-κB translocate to nucleus to induce type I interferons and inflammatory cytokines [1][3]

• MAVS forms prion-like aggregates that amplify signaling
• TRAF proteins (TRAF2, TRAF3, TRAF6) are recruited to MAVS
• This creates a robust and rapid antiviral response [3]

Mitochondrial Platform Function

MAVS exploits unique mitochondrial properties for signaling:

Spatial Organization: Mitochondrial membrane provides organized platform for signal assembly Metabolic Integration: MAVS signaling is influenced by mitochondrial metabolic state Quality Control: Mitophagy pathways regulate MAVS turnover [6]

Innate Immunity in the Brain

In the central nervous system, MAVS-mediated signaling provides antiviral protection:

Neuronal Defense: Neurons express MAVS and can mount interferon responses to viral infection [14] Microglial Activation: MAVS in microglia detects viral RNA and triggers cytokine production Astrocyte Responses: Astrocyte MAVS contributes to neuroinflammatory responses [18]

Mechanisms in Neurodegeneration

Alzheimer's Disease

MAVS plays a complex role in AD pathogenesis:

Type I Interferon Signature: AD brains exhibit elevated type I interferon-stimulated genes (ISGs), indicating chronic activation of the MAVS pathway. This interferon signature correlates with disease severity and is thought to contribute to synaptic dysfunction and cognitive decline [4][15].[@ifn_signature]

Amyloid-Beta Interaction: Amyloid-beta oligomers can activate RIG-I-MAVS signaling in microglia and neurons. Aβ binding to RIG-I triggers MAVS aggregation and downstream inflammatory responses, creating a vicious cycle of amyloid deposition and neuroinflammation [11].

MAVS-Dependent Neurotoxicity: Chronic MAVS activation in neurons leads to:

• Prolonged interferon response
• Synaptic gene dysregulation
• Increased excitotoxicity
• Neuronal apoptosis

Parkinson's Disease

MAVS contributes to PD pathogenesis through several mechanisms:

Alpha-Synuclein Interaction: Alpha-synuclein aggregates can activate RIG-I-MAVS pathway in microglia. Recent studies show that α-syn fibrils bind to RIG-I and trigger MAVS-dependent cytokine production, linking protein aggregation to innate immune activation [12].[@alpha_syn_microglia]

Dopaminergic Neuron Vulnerability: MAVS is expressed in dopaminergic neurons of the substantia nigra. Viral infection or mitochondrial stress can activate MAVS, leading to interferon responses that promote neuronal death [5].

Neuroinflammation: MAVS-mediated chronic inflammation in PD:

• Activates microglia in substantia nigra
• Promotes TNF-α, IL-1β, and IL-6 production
• Contributes to progressive dopaminergic neuron loss

Amyotrophic Lateral Sclerosis

MAVS dysregulation in ALS:

• Elevated MAVS expression in motor neurons
• Contribution to excitotoxicity through interferon signaling
• Interaction with ALS-associated proteins like SOD1 and TDP-43

Multiple Sclerosis

While primarily an autoimmune demyelinating disease, MS involves:

• MAVS-dependent antiviral responses in glia
• Chronic interferon signature similar to other neuroinflammatory conditions

Molecular Interactions

Protein-Protein Interactions

MAVS interacts with numerous proteins:

Upstream Sensors:

• RIG-I (DDX58) - viral RNA detection
• MDA5 (IFIH1) - viral RNA detection
• LGP2 - regulatory function

• TBK1 - kinase
• IKKε - kinase
• IKKβ - NF-κB activation
• IRF3/7 - transcription factors

• TRAF2/3/6 - ubiquitin signaling
• FADD - apoptosis signaling
• RIP1 - NF-κB activation

• VDAC - metabolite transport
• Mitofusins - mitochondrial dynamics
• PINK1/Parkin - mitophagy [6][16]

Signaling Pathways

MAVS integrates with multiple pathways:

Genetic Associations

Disease-Associated Variants

| Variant | Disease | Effect | Evidence |
|---------|---------|--------|----------|
| rs1131559 | AD | Risk allele | GWAS [4] |
| rs3747518 | PD | Altered function | Case-control [5] |
| Various | MS | Risk alleles | GWAS |

Expression Changes

Alzheimer's Disease:

• Elevated MAVS mRNA in prefrontal cortex
• Increased MAVS protein in hippocampus
• Correlation with tau pathology burden [4][15]

• Increased MAVS in substantia nigra
• Higher MAVS in peripheral blood mononuclear cells [5]

• MAVS expression increases with age in human brain
• Contributes to age-related neuroinflammation

Cellular and Tissue Distribution

Brain Expression

MAVS is expressed in all major brain cell types:

Neurons: High expression in cortical and hippocampal neurons. Neuronal MAVS responds to viral infection and can trigger cell-autonomous antiviral responses [14].

Astrocytes: Moderate expression in astrocytes. Astrocyte MAVS contributes to neuroinflammatory cytokine production and can respond to neuronal damage signals [18].

Microglia: High expression in microglia. Microglial MAVS is the primary sensor for viral RNA and a major source of MAVS-dependent neuroinflammation [12].

Subcellular Localization

• Mitochondrial outer membrane: Primary location
• Peroxisomes: Secondary site for signaling
• Cytosol: Soluble pool for signal transduction
• Nucleus: Minor nuclear functions

Therapeutic Implications

Therapeutic Strategies

Targeting MAVS signaling offers potential for neurodegenerative disease treatment:

Anti-inflammatory Approaches:

• RIG-I antagonists to reduce MAVS activation
• TBK1 inhibitors to block downstream signaling
• NF-κB inhibitors to reduce cytokine production

• Type I interferon receptor blockers
• JAK-STAT inhibitors to reduce interferon signaling

• Mitophagy enhancers to clear damaged mitochondria
• MAVS degradation-promoting compounds [19]

Biomarker Potential

MAVAS as a biomarker:

• Peripheral blood MAVS expression correlates with CNS inflammation
• Cerebrospinal fluid interferon signature reflects MAVS activity
• May predict treatment response to immunomodulatory therapies [20]

Challenges

• Achieving brain penetration with small molecules
• Balancing antiviral protection with immunosuppression
• Timing of intervention in disease course

Research Directions

Key Unanswered Questions

Ongoing Research

• RIG-I agonist/antagonist development for CNS applications
• Biomarker studies measuring interferon signatures
• Animal model studies of MAVS in neurodegeneration

Cross-Linking Relationships

MAVS connects to multiple key pathways:

Related Genes

• [RIG-I (DDX58)](/genes/ddx58) - upstream sensor
• [MDA5 (IFIH1](/genes/ifih1) - upstream sensor
• [cGAS (MB21D1)](/genes/mb21d1) - cross-talk pathway
• [STING (TMEM173)](/genes/tmem173) - cross-talk pathway

Related Mechanisms

• [Innate Immunity](/mechanisms/innate-immune-response)
• [Neuroinflammation](/mechanisms/neuroinflammation-neurodegeneration)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction-parkinsons)
• [Type I Interferon Response](/mechanisms/interferon-signaling-neurodegeneration)
• [Inflammasome Activation](/mechanisms/inflammasome-neurodegeneration)

Related Diseases

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Viral Encephalitis](/diseases/viral-encephalitis)

See Also

• [MAVS Protein](/proteins/mavs-protein)
• [Genes Index](/genes)
• [RIG-I-Like Receptor Signaling](/mechanisms/rig-i-signaling)
• [Mitochondrial Innate Immunity](/mechanisms/mitochondrial-innate-immunity)
• [Neuroinflammation Pathway](/mechanisms/neuroinflammation-neurodegeneration)

External Links

• [NCBI Gene: MAVS](https://www.ncbi.nlm.nih.gov/gene/57468)
• [UniProt: Q9Y2H9](https://www.uniprot.org/uniprot/Q9Y2H9)
• [OMIM: 609588](https://www.omim.org/entry/609588)
• [GeneCards: MAVS](https://www.genecards.org/cgi-bin/carddisp.pl?gene=MAVS)
• [HGNC: MAVS](https://www.genenames.org/data/hgnc_data.php?hgnc_id=21382)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving MAVS Gene discovered through SciDEX knowledge graph analysis: